| Message from the Director | History | Organization |
 |
In 1998, the Institute for Frontier Medical Sciences (IFMS) was established through the reorganization of the Chest Disease Institute and Research Center for Biomedical Engineering with the main aim of performing regenerative medicine research. Since its establishment, IFMS has been contributing to the development of human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells. The Stem Cell Research Center for ES cell research and Research Center for Nano Medical Engineering were developed within the IFMS. IFMS was acknowledged as a Joint Usage/Research Center for regenerative medicine by the Ministry of Education, Culture, Sports, Science and Technology/Japan. We would like to express our deepest gratitude to the Office of the University President and the people concerned for their continuous support during these 13 years.
Advances in stem cell science, basic research in regenerative medicine, and their clinical application are expected to arise from IFMS activities. Many research institutes for regenerative medicine have been established with a focus on specific issues, stem cell research, or tissue engineering, reflecting their specific background. Fortunately, IFMS retains researchers whose specialties are stem cells, basic biology, surgery, and tissue engineering. Members of IFMS should continue to advance their own research pursuits, and the time has come for initiating collaborations to realize the goals of regenerative medicine. IFMS has been continuously forwarding its role as a center for regenerative medicine.
Hiroo Iwata,Ph.D
Director
Institute for Frontier Medical Sciences
Kyoto University |
 |
|
Human Embryonic Stem Cell Project
